Eren Celik
Papers
6
Total Citations
135
H-Index
5
About
Eren Celik is a radiation oncology researcher whose work centers on stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), with a particular focus on oligometastatic disease and advanced robotic treatment platforms such as CyberKnife. His research has meaningfully shaped clinical understanding of how precision radiotherapy can be applied across diverse metastatic settings, including brain, adrenal, and lung metastases. Among his most influential contributions is his investigation into combining robotic SRS with anti-PD-1 immunotherapy in melanoma patients with brain metastases, a timely and widely cited work that has garnered 45 citations and helped define the emerging synergy between radiotherapy and immune checkpoint inhibition. His 2017 study on adrenal metastases in oligometastatic non-small cell lung cancer further expanded the evidence base for SBRT in challenging anatomical sites. Celik has also made important methodological contributions, notably proposing new response criteria to distinguish pseudoprogression from true recurrence in vestibular schwannomas following SRS — a clinically critical distinction. His involvement in the multicenter RAVENTA trial for cardiac radioablation highlights his reach into innovative and cross-disciplinary applications of radiosurgery, underscoring his standing as a versatile and impactful voice in modern radiation oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6